Early diagnosis means
early intervention

Clarifi ASD is a clinically validated test aiding in
the diagnosis of autism spectrum disorder.

Early diagnosis means
early intervention

Clarifi is a clinically validated test aiding in
the diagnosis of autism spectrum disorder.

Clarifi ASD in the news

The Clarifi autism
saliva test

Clarifi ASD is designed to provide a probability of an autism diagnosis based on epigenetic biomarkers in the saliva. It is currently available to children 18 months through 6 years of age.

non invasive autism test, saliva test for autism

Non-invasive and easily administered saliva test

Clarifi autism saliva test, rapid results, fast results, results in 3 to 6 weeks

Accelerates the diagnostic process with results in 3 to 6 weeks

Clarifi, Clarifi autism saliva test, clinically validated

Peer-reviewed research and clinically validated

epigenetic saliva test for autism, autism saliva test, epigenetic autism test, Clarifi autism test

Measures epigenetic molecules in saliva

Is your child eligible for Clarifi ASD?

Clarifi ASD is currently available to children who meet the following eligibility requirements.

Suspicion of autism

For children with a clinical suspicion of autism, such as a positive screen on

Appropriate age range

Must be 18 months through 6 years of age

Meets geographic requirements

Clarifi ASD is currently available in the U.S., excluding New York State

Ready to talk to your child’s health care provider about Clarifi ASD?

The road to Clarifi ASD

Read about our team’s journey translating a medical discovery into an innovative clinical product.


Rising autism prevalence and
longer wait times for diagnosis

According to the CDC, 1 in 54 children in the U.S. are diagnosed with ASD. Even though ASD can be clinically diagnosed as early as 2 years, the average age of diagnosis is currently 4 years of age. A biological, diagnostic tool can further inform clinical judgment and substantially improve early identification.


“There has clearly been an increase in prevalence of autism spectrum disorder in our society. Our goal is to facilitate diagnosis in younger children and maximize the potential for interventions to improve abilities, outcomes and quality of life.”

Kayla Wagner
Vice President – Product Management


Cutting-edge breakthroughs in epigenetic research

Clarifi ASD is not a genetic test. It is the product of scientific advancements in the area of epigenetics; the factors that influence how genes are turned on and off. Our peer-reviewed research discovered that certain RNA molecules that regulate genetic activity and reflect interactions between a patient and their environment, were different in children with autism.


Translating the science into practical solutions

The next step was turning this novel discovery into a clinically available test to help families.  To accomplish this, Admera Health, a CLIA-certified Laboratory, developed and validated the Clarifi autism saliva test by incorporating Quadrant Biosciences’ unique bioinformatics platform.

Translating the science into practical solutions


First ever epigenetic
test for autism

Clarifi ASD is beginning to have a positive impact on families. Here is one parent’s perspective on how the saliva test helped her family.

“A test which can separate children who have screened M-CHAT positive into high likelihood of autism or low likelihood of autism could help streamline waitlists and permit earlier diagnosis and enrollment in autism treatment.”

Dr. Daniel Coury MD
Professor of Pediatrics and Psychiatry at College of Medicine at The Ohio State University and the Section of Developmental and Behavioral Pediatrics for Nationwide Children’s Hospital
Diagnosis is only the first step


Diagnosis is only the first step

Quadrant Biosciences is proud to support Autism Speaks in providing resources and solutions to individuals and families touched by autism. In your patient account, you will find links to resources such as toolkits, local service provider directories and other helpful information.
Autism Speaks is dedicated to promoting solutions, across the spectrum and throughout the lifespan, for the needs of individuals and their families.

Diagnosis is only the first step


We’ve partnered with top
research and support organizations

Quadrant Biosciences is privileged to be aligned with a number of top autism research and support organizations

“As a company, we are committed to looking outside ourselves, and deploying our resources to assist other organizations and research efforts dedicated to improving the lives of people with autism and their families.”

Richard Uhlig
Founder and CEO


Interested in getting your child tested? Download, print, and bring this information to your child’s health care provider.

Health care providers

Ready to offer Clarifi ASD to your patients? Get started by completing the online application.

Subscribe to Clarifi ASD

Get important details in your inbox